PAVmed (PAVM) Shares Outstanding (Diluted Average) (2022 - 2025)

PAVmed has reported Shares Outstanding (Diluted Average) for 4 years, with the latest figure at $670466.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 69.15% year-over-year to $670466.0; the trailing twelve-month figure through Dec 2025 stood at $670466.0 (down 69.15% YoY), and the FY2025 full-year result was $670466.0, down 69.15% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $670466.0, down from $21.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $89.8 million in Q3 2022, with the low at $670466.0 in Q4 2025.
• Average Shares Outstanding (Diluted Average) over 4 years is $23.0 million, with a median of $8.0 million recorded in 2023.
• Year-over-year, Shares Outstanding (Diluted Average) sank 92.28% in 2023 and jumped 503.76% in 2025.
• Tracing PAVM's Shares Outstanding (Diluted Average) over 4 years: stood at $5.9 million in 2022, then gained by 21.78% to $7.2 million in 2023, then sank by 69.95% to $2.2 million in 2024, then plunged by 69.15% to $670466.0 in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $670466.0 (Q4 2025), $21.6 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.

Peer Comparison